At the time of writing, Silk Road Medical Inc [SILK] stock is trading at $17.69, up 1.14%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The SILK shares have gain 2.61% over the last week, with a monthly amount glided 12.46%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 28, February 2024, Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook. In a post published today on Yahoo Finance, Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2023.
From an analyst’s perspective:
Silk Road Medical Inc [NASDAQ: SILK] stock has seen the most recent analyst activity on January 19, 2024, when Stifel upgraded its rating to a Buy and also boosted its price target to $20 from $9. Previously, Lake Street started tracking the stock with Buy rating on January 03, 2024, and set its price target to $20. On October 24, 2023, upgrade upgraded it’s rating to Peer Perform. Stifel downgraded its rating to a Hold and decreased its price target to $12 on October 11, 2023. CL King downgraded its rating to a Neutral. Citigroup downgraded its rating to Sell for this stock on October 11, 2023, and downed its price target to $8. In a note dated October 11, 2023, B. Riley Securities downgraded an Neutral rating on this stock and revised its target price from $54 to $14.
For the past year, the stock price of Silk Road Medical Inc fluctuated between $6.08 and $54.69. Currently, Wall Street analysts expect the stock to reach $39.67 within the next 12 months. Silk Road Medical Inc [NASDAQ: SILK] shares were valued at $17.69 at the most recent close of the market. An investor can expect a potential return of 124.25% based on the average SILK price forecast.
Analyzing the SILK fundamentals
According to Silk Road Medical Inc [NASDAQ:SILK], the company’s sales were 169.94M for trailing twelve months, which represents an 18.89% jump. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at -0.34%, Pretax Profit Margin comes in at -0.33%, and Net Profit Margin reading is -0.32%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -0.35 and Total Capital is -0.24. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.5.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.22 points at the first support level, and at 16.76 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.15, and for the 2nd resistance point, it is at 18.62.
Silk Road Medical Inc [SILK] reported earnings per share of -$0.33 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.35/share, meaning a difference of $0.02 and a surprise factor of 5.70%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.35 per share as compared to estimates of -$0.39 per share, a difference of $0.04 representing a surprise of 10.30%.
Ratios To Look Out For
It is important to note that Silk Road Medical Inc [NASDAQ:SILK] has a current ratio of 10.03. Also, the Quick Ratio is 9.11, while the Cash Ratio stands at 1.22. Considering the valuation of this stock, the price to sales ratio is 4.05, the price to book ratio is 4.49.
Transactions by insiders
Recent insider trading involved Jones Marie L., CAO and VP, Finance, that happened on Oct 27 when 656.0 shares were sold. COO/CFO, Buchanan Lucas W. completed a deal on Oct 04 to sell 2662.0 shares. Meanwhile, EVP/Chief Legal Officer/Sec. Klemz Kevin M sold 1539.0 shares on Aug 17.
